ECCO 2019 European Cancer Summit


ECCO 2019 European Cancer Summit

Reaching the 70:35 Vision for cancer – 70% long term survival for all cancer patients across Europe by 2035 – requires breaking down the borders of cancer care: between countries, professions, sectors and stakeholders.

Join us to chart how to make that happen sooner, and be part of the border-breaking community in cancer care!

The ECCO 2019 European Cancer Summit will:

  • Debate leading-edge ideas in achieving improvement in cancer care
  • Determine consensus resolutions for improving health care systems
  • Decide on an action plan for the way forward to ensure ideas translate into policies that will impact daily clinical practice

Why should you attend?

  • The Summit unites the multidisciplinary community
  • Share knowledge and drive the debate on achieving improvement in cancer care
  • Demand the changes required to improve patient outcomes
  • Engage in resolution-forming to shape the EU cancer policy agenda
  • Translating ideas into policies that will impact daily clinical practice
  • Network with leaders from cancer health care, patient advocacy and stakeholder communities
  • Represent your organisation’s voice to the change-making community of European cancer care

Who should attend?

Current and future leadership and officers from staff and professional levels of:  

  • Representatives of ECCO Member Societies 
  • Patient organisations including patient advocates
  • Healthcare providers including hospitals, cancer centres and oncology departments
  • Healthcare insurance providers and other payer organisations
  • Education providers
  • Commercial providers to the healthcare sector
  • EU and national/regional government officials
  • Public affairs professionals
  • Elected policy makers in the healthcare sector
  • Academic researchers
  • Regulatory professionals

As with all ECCO events, a special feature is the collaboration between our different member societies and ECCO Patient Advisory Committee in producing high-quality, stimulating and illuminating sessions, and providing a platform for neglected aspects in the cancer policy debate to receive attention.  


Frequently Asked Questions